Program Design
Main Conference
Opening Ceremony
Nobel Laureate Forum
Keynote Forum
Sino-India Cooperation Forum
Track 1: Global Policies, Current Challenges and Market Trend
Session 101: Global Approval Policies, Legal, Patent Access, IP Strategies and Regulations
Session 102: Current Challenges and Issues
Session 103: Future Market Trend
Track 2: Next Generation Biosimilars R & D
Session 201: The Latest Strategies for Biosimilars Development
Session 202: Innovative Technologies and Approaches in Biosimilar R&D
Session 203: New Preclinical Development
Track 3: Future Clinical Applications
Session 301: Clinical Trials and Testing of Biosimilars: New FDA Approaches
Session 302: Biosimilars in Oncology
Session 303: Insulin Biosimilars for Diabetes
Session 304: Biosimilars for Immune-Mediated Chronic Diseases
Track 4: Green Bioprocessing and Biomanufacturing
Session 401: Next Generation Upstream & Downstream Bioprocesses
Session 402: GMP, GCP and Quality Control
Session 403: Biosimilar Development, Green Manufacturing and Analysis
Track 5: Business Development and Outsourcing Services
Session 501: Commercialization of Biosimilars and Sustainability of the Industry
Session 502: New Cooperation Model and Investment in Biosimilars
Session 503: Recent Developments and Global Trends in Biosimilars CMO & CRO Market
Track 6: Projects & Talents Matchmaking Forum
Dalian International Conference Center, China
Due to the recent COVID-19 Outbreak, we have to postpone this event from April 25-28 to September 19-22，2021. it has brought us more than sadness but gratitude and inspiration, we would express our deep appreciation to your previous contribution and all broad public supports, wish you could be part of us again!
Dr. Michel Mikhail
Global Expert in
Biosimilars and
International Expert in
Regulatory Affairs
|
©2018-2021 All right reserved by BIT Congress Inc. |